77799 Ortenberg, de
+49 (781) 9696-835
Team Marburg celebrates victory at iGEM Giant Jamboree 2018 in the overgraduate section
Over 200 interested participants attended the public lecture at the magnificent auditorium of the Philipps-University. Surrounded by ancient paintings and chandeliers, the team presented its award-winning work. Dr Silke Angersbach, who acted as contact person from BMG LABTECH and introduced the device to the students, attended the talk as well: „We are very pleased that we were able to support such a successful team. The students achieved fantastic results. Sincere congratulations“, said Dr Silke Angersbach.
The young scientists focused on the bacteria Vibrio natriegens as an alternative to E. coli bacteria. In their project, the team developed three different cell lines: VibriClone, VibriExpress and VibriInteract. The main advantage of these organisms is their rapid growth. Since Vibrio natriegens duplicate every seven minutes, experimental times can potentially be shortened, hence reducing lab costs. By awarding the team, the jury honours the project as forward-looking.
„The CLARIOstar was the key to the success of our project. We were able to generate foundational characterization data for genetic parts in V. natriegens, which is a crucial part for establishing
V. natriegens as the next workhorse for synthetic biology. By characterizing all the different parts, we were able to win the special prize categorie "best part collection" and in the end the Grand Prize of the iGEM competition“, said René Inckemann from Philipps-University Marburg.
iGEM (international Genetically Engineered Machine) is an annual international competition in synthetic biology. Through the participation young researchers will have the possibility to realize a scientific project on their own. The winners are announced during the „Giant Jamboree“ at MIT in Boston, USA.
The use of information published here for personal information and editorial processing is generally free of charge. Please clarify any copyright issues with the stated publisher before further use. In the event of publication, please send a specimen copy to email@example.com.